Skip to main content
Log in

Oral Tolerance

  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

Oral tolerance is the immunologic mechanism by which the mucosal immune system maintains unresponsiveness to the myriad of antigens in the mucosal environment which might otherwise induce untoward immune responses. Recent studies have shown that it is mediated by several distinct, yet interacting mechanisms including the generation of suppressive T cells producing antigen nonspecific cytokines and the induction of clonal deletion and/or anergy. In this review of oral tolerance, we discuss these mechanisms in detail and show how oral tolerance or lack therof may explain the occurrence of mucosal inflammation. In addition, we discuss how induction of oral tolerance can be used to treat autoimmune states.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Asherson GL, Zembala M, Perera MACC, Mayhew B, Thomas WR: Production of immunity and unresponsiveness in the mouse by feeding contact sensitizing agents, and the role of suppressor cells in the Peye's patches, mesenteric lymph nodes and other lymphoid tissues. Cell Immunol 33:145–155, 1977

    Google Scholar 

  2. Tomasi TB: Oral tolerance. Transplantation 29:353–356, 1980

    Google Scholar 

  3. Kagnoff MF: Effects of antigen-feeding on intestinal and systemic immune responses. II. Suppression of delayed type hypersensitivity reactions. J Immunol 120:1509–1513, 1978

    Google Scholar 

  4. MacDonald TT: Immunosuppression caused by antigen feeding. II. Suppressor T cells mask Peyer's patches B cell priming to orally administered antigen. Eur J Immunol 13:138–142, 1983

    Google Scholar 

  5. Stokes CR, Newby TJ, Huntley JH, Patel D, Bourne FJ: The immune response of mice to bacterial antigens given by mouth. Immunology 38:497–502, 1979

    Google Scholar 

  6. Titus RG, Chiller JM: Orally induced tolerance: Definition at the cellular level. Int Arch Allergy Appl Immunol 65:323–338, 1981

    Google Scholar 

  7. Reese RT, Cebra JJ: Anti-dinitrophenyl antibody production in strain 13 guinea pigs fed or sensitized with dinitrochlorobenzene. J Immunol 114:863–871, 1975

    Google Scholar 

  8. Aizpura H, Russell-Jones G: Oral vaccination. Identification of classes of proteins that provoke an immune response upon oral feeding. J Exp Med 167:440–451, 1988

    Google Scholar 

  9. Elson CO, Ealding W: Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. J Immunol 132:2736–2741, 1984

    Google Scholar 

  10. Mowat AM, Thomas JJ, Parrott DMV: Divergent effects of bacterial lipopolysaccharide on immunity to orally administered protein and particular antigens in mice. Immunology 58:677–684, 1986

    Google Scholar 

  11. Strobel S, Ferguson A: Persistence of oral tolerance in mice fed ovalbumin is different for humoral and cell-mediated immune responses. Immunology 60:317–318, 1987

    Google Scholar 

  12. Zhang X, Brunner T, Carter L, Dutton, R, Rogers P, Bradley L, Sato T, Reed J, Green D, Swain S: Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis. J Exp Med 185:1837–1849, 1997

    Google Scholar 

  13. Ngan J, Kind LS: Suppressor T cells for IgE and IgG in Peyer's patches of mice made tolerant by the oral administration of ovalbumin. J Immunol 120:861–865, 1978

    Google Scholar 

  14. Sacklayen MG, Pesce AJ, Pollak VE, Michael JG: Kinetics of oral tolerance: Study of variables affecting tolerance induced by oral administration of antigen. Int Arch Allergy Appl Immunol 73:5–9, 1984

    Google Scholar 

  15. Challacombe SJ, Tomasi JB: Systemic tolerance and secretory immunity after oral immunization. J Exp Med 152:1459–1472, 1980

    Google Scholar 

  16. Fujihashi K, McGhee J, Yamamoto M, Hiroi T, Kiyono H: Role of lambda-delta T cells in the regulation of mucosal IgA response and oral tolerance. In Oral Tolerance, H. Weiner, L. Mayer (eds). New York: The New York Academy of Sciences, 1996, pp 55–63

    Google Scholar 

  17. Gesualdo L, Lamm ME, Emancipator S: Defective oral tolerance promotes nephritogenesis in experimental IgA nephropathy induced by oral immunization. J Immunol 145:3684–3691, 1990

    Google Scholar 

  18. Richman L, Chiller J, Brown W, Hanson D, Vaz N: Enterically induced immunologic tolerance. I. Induction of suppressor T lymphocytes by intragastric administration of soluble proteins. J Immunol 121:2429–2434, 1978

    Google Scholar 

  19. Elson C, Edding W: Generalised systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. J Immunol 132:2736–2741, 1984

    Google Scholar 

  20. Kagnoff M, Cambell S: Functional characteristics of Peyer's patch lymphoid cells I. Induction of humoral antibody and cell-mediated allograft reactions. J Exp Med 139:398, 1974

    Google Scholar 

  21. Chase M, Battisto J: The duration of dermal sensitization following cellular transfer in guinea pigs. J Allergy 26:83, 1955

    Google Scholar 

  22. Thomas HC, Ryan CJ, Benjamin IS, Blumgart LH, MacSween RN: The immune response in cirrhotic rats. The induction of tolerance to orally administered protein antigens. Gastroenterology 71:114–117, 1976

    Google Scholar 

  23. Richman LK, Graeff AS, Strober W: Antigen presentation by macrophage-enriched cells from the mouse Peyer's patch. Cell Immunol 62:110–118, 1981

    Google Scholar 

  24. MacDonald T: Immunosuppression caused by antigen feeding. I. Evidence for the activation of a feedback suppressor pathway in the spleens of antigen-fed mice. Eur J Immunol 12:767–773, 1982

    Google Scholar 

  25. Nussenblatt R, Caspi R, Mahdi R, et al.: Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. J Immunol 144:1689–1696, 1990

    Google Scholar 

  26. Lider O, Santos L, Lee C, Higgins P, Weiner H: Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. II. Suppression of disease and in vitro responses is mediated by antigen-specific CD8+ T lymphocytes. J Immunol 142:748–752, 1989

    Google Scholar 

  27. Vistica B, Chanaud N, Felix N, et al.: CD8 T-cells are not essential for the induction of “low-dose” oral tolerance. Clin Immunol Immunopathol 78:196–202, 1996

    Google Scholar 

  28. Chen Y, Inobe J, Weiner H: Induction of oral tolerance to myelin basic protein in CD8-depleted mice: Both CD4+ and CD8+ cells mediate active suppression. J Immunol 155:910–916, 1995

    Google Scholar 

  29. Tada Y, Ho A, Koh D-R, Mak T: Collagen-induced arthritis in CD4-or CD8-deficient mice. CD8+ T cells play a role in initiation and regulate recovery phase of collagen-induced arthritis. J Immunol 156:4520–4526, 1996

    Google Scholar 

  30. Desvignes C, Bour H, Nicolas J, Kaiserlian D: Lack of oral tolerance but oral priming for contact sensitivity to dinitroflorobenzene in major histocompatibility complex class II-deficient mice and in CD4+ T cell-depleted mice. Eur J Immunol 26:1756–1761, 1996

    Google Scholar 

  31. Miller A, Lider O, Weiner H: Antigen-driven bystander suppression after oral administration of antigens. J Exp Med 174:791–798, 1991

    Google Scholar 

  32. Miller A, Al-Sabbagh A, Santos L, Prabhu-Das M, Weiner H: Epitopes of myelin basic protein (MBP) that trigger TGF-β release following oral tolerization to MBP are different from encephalitogenic epitopes. J Immunol 151:7307–7315, 1993

    Google Scholar 

  33. Von Herrath M, Dyrberg T, Oldstone M: Oral insulin treatment suppresses virus-induced antigen-specific destruction of beta cells and prevents autoimmune diabetes in transgenic mice. J Clin Invest 98:1324–1331, 1996

    Google Scholar 

  34. Schluesener H, Lider O: Transforming growth factors beta 1 and beta 2: Cytokines with identical immunosuppressive effects and a potential role in the regulation of autoimmune T cell function. J Neuroimmunol 24:249–258, 1989

    Google Scholar 

  35. Karpus W, Swanborg R: CD4+ suppressor cells inhibit the function of effector cells of experimental autoimmune encephalomyelitis through a mechanism involving transforming growth factor β. J Immunol 146:1163–1169, 1991

    Google Scholar 

  36. Higgins P, Weiner H: Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J Immunol 140:440–445, 1988

    Google Scholar 

  37. Nagler Anderson C, Bober L, Robinson M, Siskind G, Thorbecke G: Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II antigen. Proc Natl Acad Sci USA 83:7443, 1986

    Google Scholar 

  38. Khoury SJ, Hancock WW, Weiner HL: Oral tolerence to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, prostaglandin E expression in the brain. J Exp Med 176:1355–1364, 1992

    Google Scholar 

  39. Miller A, Lider O, Roberts A, Sporn M, Weiner H: Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor after antigen-specific triggering. Proc Natl Acad Sci USA 89:421–425, 1992

    Google Scholar 

  40. Powrie F, Correa-Oliveira R, Mauze S, Coffman R: Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity. J Exp Med 179:589–600, 1994

    Google Scholar 

  41. Powrie F, Carlino J, Leach M, Mauze S, Coffman R: A critical role for transforming growth factor-β but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RBlow CD4+ T cells. J Exp Med 183:2669–2674, 1996

    Google Scholar 

  42. Neurath M, Fuss I, Kelsall B, Stuber E, Strober W: Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med 182:1281–1290, 1995

    Google Scholar 

  43. Neurath M, Fuss I, Kelsall B, Presky D, Waegell W, Strober W: Experimental granulomatous colitis in mice is abrogated by induction of TGFβ-mediated oral tolerance. J Exp Med 183:2605–2616, 1996

    Google Scholar 

  44. Miller A, Zhang Z, Sobel R, Al-Sabbagh A, Weiner H: Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. VI. Suppression of adoptively transferred disease and differential effects of oral vs. intravenous tolerization. J Neuroimmunol 46:73–82, 1993

    Google Scholar 

  45. Kearney E, Pape K, Loh D, Jenkins M: Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1:327–339, 1994

    Google Scholar 

  46. Perez V, Van Parijs L, Biuckians A, Zheng X, Strom T, Abbas A: Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity 6:411–417, 1997

    Google Scholar 

  47. Kulkarni A, Huh C, Becker D, et al.: Transforming growth factor-β1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 90:770–774, 1993

    Google Scholar 

  48. Marth T, Strober W, Kelsall B: High dose oral tolerance in ovalbumin TCR transgenic mice: Systemic neutralization of interleukin-12 augments TGFβ secretion and T cell apoptosis. J Immunol 157:2348–2357, 1996

    Google Scholar 

  49. Marth T, Strober W, Seder R, Kelsall B: Regulation of transforming growth factor-β production by interleukin-12. Eur J Immunol 27:1213–1220, 1997

    Google Scholar 

  50. Seder R, Marth T, Sieve M, Strober W, Kelsall B: Factors involved in the differentiation of TGF-β-producing cells from naive CD4+ T cells: IL-4 and IFN-gamma have opposing effects, while TGF-beta positively regulates its own products.

  51. Seder R, Paul WE: Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu Rev Immunol 12:635–673, 1994

    Google Scholar 

  52. Friedman A, Weiner H: Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc Natl Acad Sci USA 91:6688–6692, 1994

    Google Scholar 

  53. Chen Y, Inobe J, Kuchroo V, Baron J, Chaneway C, Weiner H: Oral tolerance in myelin basic protein T-cell receptor transgenic mice: Suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells. Proc Natl Acad Sci USA 93:388–391, 1996

    Google Scholar 

  54. Chen Y, Kuchroo V, Inobe J, Hafler D, Weiner H: Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalitis. Science 265:1237–1240, 1994

    Google Scholar 

  55. Chen Y, Weiner H: Dose-dependent activation and deletion of antigen-specific T cells following oral tolerance. Ann NY Acad Sci 778:111–121, 1996

    Google Scholar 

  56. Inobe JI, Chen Y, Weiner HL: In vivo administration of IL-4 induces TGFβ producing cells and protects animals from experimental autoimmune encephalomyelitis. Ann NY Acad Sci 778:390–392, 1996

    Google Scholar 

  57. Weiner H: Oral tolerance: Immune mechanisms and treatment of autoimmune diseases. Immunol Today 18:335–343, 1997

    Google Scholar 

  58. Fukaura H, Kent S, Pietrusewic M, Khoury S, Weiner H, Hafler D: Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-β-1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J Clin Invest 98:70–77, 1996

    Google Scholar 

  59. Caspi R, Stiff L, Morawetz N, et al.: Cytokine-dependent modulation of oral tolerance in a murine model of autoimmune uveitis. Ann NY Acad Sci 778:315–337, 1996

    Google Scholar 

  60. Garside P, Steel E, Worthey A, et al.: Th2 cells are subject to high dose oral tolerance and are not essential for its induction. J Immunol 154:3549–3555, 1995

    Google Scholar 

  61. Chen Y, Inobe J, Marks R, Gonella P, Kuchroo V, Weiner HL: Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 376:177–180, 1995

    Google Scholar 

  62. Ehrhardt R, Ludviksson B, Gray B, Neurath M, Strober W: Induction and prevention of colonic inflammation in IL-2-deficient mice. J Immunol 158:566–573, 1997

    Google Scholar 

  63. Ludviksson B, Gray B, Strober W, Ehrhardt R: Dysregulated intrathymic development in the IL-2-deficient mouse leads to colitis-inducing thymocytes. J Immunol 158:104–111, 1997

    Google Scholar 

  64. Marinaro M, Staats H, Hiroi T, Jackson R, Coste M, Boyaka P, Okahashi N, Yamamoto M, Kiyono H, Bluethmann H, Fujihashi K, McGhee J: Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4. J Immunol 155:4621–4629, 1995

    Google Scholar 

  65. Ke Y, Pearce K, Lake J, Ziegler H, Kapp J: Gamma delta T lymphocytes regulate the induction and maintenance of oral tolerance. J Immunol 158:3610–3618, 1997

    Google Scholar 

  66. Ke J, Kapp J: Oral Antigen inhibits priming of CD8+ CTL, CD4+ T cells, and antibody responses while activating CD8+ suppressor T cells. J Immunol 156:916–921, 1996

    Google Scholar 

  67. Mengel J, Cardillo F, Aroeira L, Williams O, Russo M, Vaz N: Anti-gamma delta T cell antibody blocks the induction and maintenance of oral tolerance to ovalbumin in mice. Immunol Lett 48:97–102, 1995

    Google Scholar 

  68. Wildner G, Hunig T, Thurau S: Orally induced, peptide-specific gamma/delta TCR+ cells suppress experimental autoimmune uveitis. Eur J Immunol 26:2140–2148, 1996

    Google Scholar 

  69. Harrison L, Dempsey-Collier M, Kramer D, Takahashi K: Aerosol insulin induces regulatory CD8 gamma delta T cells that prevent murine insulin-dependent diabetes. J Exp Med 184:2167–2174, 1996

    Google Scholar 

  70. McMenamin C, Pimm C, McKersey M, Holt P: Regulation of IgE responses to inhaled antigen in mice by antigen-specific γδ T cells. Science 265:1869–1871, 1994

    Google Scholar 

  71. McMenamin C, McKersey M, Kuhnlein P, Hunig T, Holt P: Gamma delta T cells down-regulate primary IgE responses in rats to inhaled soluble protein antigens. J Immunol 154:4390–4394, 1995

    Google Scholar 

  72. Blumberg R, Balk S: Intraepithelial lymphocytes and their recognition of non-classical MHC molecules. Int Rev Immunol 11:15–30, 1994

    Google Scholar 

  73. Blumberg R, Terhorst C, Bleicher P, et al.: Expression of a nonpolymorphic MHC class I-like molecule CD1d, by human intestinal epithelial cells. J Immunol 147:2518–2524, 1991

    Google Scholar 

  74. Bruce MG, Ferguson A: Oral tolerance to ovalbumin in mice: Studies of chemically modified and of “biologically filtered” antigen. Immunology 57:627–630, 1986

    Google Scholar 

  75. Bruce M, Ferguson A: The influence of intestinal processing on the immunogenicity and molecular size of absorbed, circulating ovalbumin in mice. Immunology 159, 1986

  76. Strobel S, Mowat A, Drummond H, Pickering M, Ferguson A: Immunological responses to fed protein antigens in mice. II. Oral tolerance for CMI is due to activation of cyclophosphamide sensitive cells by gut processed antigen. Immunology 49:451–456, 1983

    Google Scholar 

  77. Peng H, Turner M, Ferguson A: The generation of a tolerogen after the ingestion of ovalbumin is time dependent and unrelated to the serum level of immunoreactive protein. Clin Exp Immunol 81:510–515, 1990

    Google Scholar 

  78. Lamont A, Bruce M, Watret K, Ferguson A: Suppression of an established DTH response to ovalbumin in mice by feeding antigen after immunization. Immunology 64:135–140, 1988

    Google Scholar 

  79. Kay R, Ferguson A: The immunological consequences of feeding cholera toxin. II. Mechanisms responsible for the induction of oral tolerance for DTH. Immunology 66:416–421, 1989

    Google Scholar 

  80. Kay R, Ferguson A: The immunological consequences of feeding cholera toxin. I. Feeding cholera toxin suppresses the induction of systemic delayed-type hypersensitivity but not humoral immunity. Immunology 66:410–415, 1989

    Google Scholar 

  81. Whitacre C, Gienapp I, Orosz C, Bitar D: Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy. J Immunol 147:2155–2163, 1991

    Google Scholar 

  82. Gregerson D, Obritsch W, Donoso L: Oral tolerance in experimental autoimmune uveoretinitis: Distinct mechanisms of resistance are induced by low dose versus high dose feeding protocols. J Immunol 151:5751–5761, 1993

    Google Scholar 

  83. Van Houten N, Blake S: Direct measurement of anergy of antigen-specific T cells following oral tolerance induction. J Immunol 157:1337–1341, 1996

    Google Scholar 

  84. Schwartz R: Immunological tolerance. In Fundamental Immunology, WE Paul (ed). New York: Raven Press, 1993, pp 677–731

    Google Scholar 

  85. Lamont AG, Mowat A. Mcl., Browning MJ, Parott DMV: Genetic control of oral tolerance to ovalbumin in mice. Immunology 63:737–739, 1988

    Google Scholar 

  86. Mowat A, Lamont A, Bruce M: A genetically determined lack of oral tolerance to ovalbumin is due to failure of the immune system to respond to intestinally derived tolerogen. Eur J Immunol 17:1673–1676, 1987

    Google Scholar 

  87. Mowat A: The regulation of immune responses to dietary protein antigens. Immunol Today 8:93–98, 1987

    Google Scholar 

  88. Brown D, Moskowitz N, Killeen N, Reiner S: A role for CD4 in peripheral T cell differentiation. J Exp Med 186:101–107, 1997

    Google Scholar 

  89. Kagnoff M: Immunology and inflammation of the gastrointestinal tract. In Gastrointestinal Diseases, MH Sleisenger, JS Fordtran (eds). 1993, pp 45–86

  90. Troncone R, Ferguson A: In mice, gluten in maternal diet primes systemic immune responses to gliaden in offspring. Immunology 64:533–537, 1988

    Google Scholar 

  91. Kiyono H, McGhee J, Wannemuehler M, Michalek S: Lack of oral tolerance in C3H/HeJ mice. J Exp Med 155:605–610, 1982

    Google Scholar 

  92. Michalek S, Kiyono H, Wannemuehler M, Mosteller L, McGhee JR: Lipopolysaccharide (LPS) regulation of the immune response: LPS influence on oral tolerance induction. J Immunol 128:1992–1998, 1982

    Google Scholar 

  93. Khoury S, Lider O, Al-Sabbagh A, Weiner H: Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. III. Synergistic effect of lipopolysaccharide. Cell Immunol 131:302–310, 1990

    Google Scholar 

  94. Strobel S, Ferguson A: Modulation of intestinal and systemic immune responses to a fed protein antigen, in mice. Gut 27:829–837, 1986

    Google Scholar 

  95. Mowat AM, Parrott DMV: Immunological responses to fed protein antigens in mice. IV. Effects of stimulating the reticuloendothelial system on oral tolerance and intestinal immunity to ovalbumin. Immunology 50:547–554, 1983

    Google Scholar 

  96. Zhang Z, Michael JG: Orally inducible immune responsiveness is abrogated by IFN-γ treatment. J Immunol 144:4163–4165, 1990

    Google Scholar 

  97. Kweon H, Fujihashi K, Yamamoto M, VanCott JL, McGhee JR, Kiyono H: Mucosally induced tolerance in IL-4-/-but not IFN gamma-/-mice. FASEB J 10:A1028, 1996

    Google Scholar 

  98. Kjerrulf M, Grdic D, Lycke N: Impaired mucosal IgA responses by intact oral tolerance in IFN-lambda receptor deficient mice. FASEB J 10:A1418, 1996

    Google Scholar 

  99. Weiner H: Oral tolerance for the treatment of autoimmune diseases. Annu Rev Med 48:341–351, 1997

    Google Scholar 

  100. Ludviksson BR, Ehrhardt RO, Strober W: TGF-beta production regulates the development of the 2,4,6-trinitrophenol-conjugated keyhole limpet hemocyanin-induced colonic inflammation in IL-2-deficient mice. J Immunol 159:3622–3628, 1997

    Google Scholar 

  101. Hornquist E, Lycke N: Cholera toxin increases T lymphocyte responses to unrelated antigens. Adv Exp Med Biol 1995:1507–1512, 1995

    Google Scholar 

  102. Marinaro M, Boyaka P, Finkelman F, Kiyono H, Jackson R, Jirillo E, McGhee J: Oral but not parenteral interleukin (IL)-12 redirects T helper 2 (Th2)-type responses to an oral vaccine without altering mucosal IgA responses. J Exp Med 185:415–427, 1997

    Google Scholar 

  103. Takahashi I, Marinaro M, Kiyono H, et al.: Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin. J Infect Dis 173:627–635, 1996

    Google Scholar 

  104. Sun J, Rask C, Olsson T, Holmgren J, Czerkinsky C: Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit. Proc Natl Acad Sci USA 93:7196–7201, 1996

    Google Scholar 

  105. Mowat A: Depletion of suppressor T cells by 2′-deoxyguanosine abrogates tolerance in mice fed ovalbumin and permits the induction of intestinal delayed-type hypersensitivity. Immunology 58:179–184, 1986

    Google Scholar 

  106. Nelson P, Akselband Y, Dearborn S, et al.: Effect of oral beta interon on subsequent immune responsiveness. In Oral Tolerance: Mechanisms and Applications, HL Weiner, LF Mayer (eds). New York: The New York Academy of Sciences, 1996, pp 145–155

    Google Scholar 

  107. Elson C, Tomasi M, Dertzbaugh M, Thaggard G, Hunter R, Weaver C: Oral-antigen delivery by way of a multiple emulsion system enhances oral tolerance. In Oral Tolerance: Mechanisms and Applications, H Weiner, L Mayer (eds). New York: The New York Academy of Sciences, 1996, Vol 778, pp 156–162

    Google Scholar 

  108. Karpus W, Lukacs N: The role of chemokines in oral tolerance. Abrogation of nonresponsiveness by treatment with antimonocyte chemotactic protein-1. In Tolerance: Mechanisms and Applications, H Weiner, L Mayer (eds). New York: The New York Academy of Sciences, 1996, pp 133–144

    Google Scholar 

  109. Strober W, Neurath MF: Immunological diseases of the gastrointestinal tract. In Clinical Immunology, RR Rich (eds). St. Louis: Mosby, 1995, pp 1401–1428

    Google Scholar 

  110. Sollid LM, Markussen G, Ek J: Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J Exp Med 169:345, 1989

    Google Scholar 

  111. Ferguson A (ed): In Models of Immunologically-Driven Small Intestinal Damage, MN Marsh (ed). Chichester: John Wiley and Sons, 1987, pp 225–252

    Google Scholar 

  112. Nilsen EM, Lundin Ke, Krajci P, Scott H, Sollid LM, Brandtzaeg P: Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon gamma. Gut 37:766–776, 1995

    Google Scholar 

  113. Strokes CR, Miller BG, Bourne FJ: Animal models of food sensitivity. In Food Alergy and Intolerance, J Brostoff, SJ Challacombe (eds). Eastbourne: Saunders, 1987, pp 286–300

    Google Scholar 

  114. Barratt MEJ, Powell JR, Allen WD, Porter P (eds): Immunopathology of intestinal disorders in farm animals. In Immunopathology of Intestinal Disorders in Farm Animals, MN Marsh (ed). Chichester: John Wiley and Sons, 1987, pp 253–258

  115. Podolsky DK: Inflammatory bowel disease. N Engl J Med 325:928–937, 1991

    Google Scholar 

  116. Fuss IJ, Neurath M, Boirivant M, Klein JS, de la Motte C, Strong SA, Fiochhi C, Strober W: Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. J Immunol 157:1261–1270, 1996

    Google Scholar 

  117. Van Dulleman HM, Van Deventer SJ, Hommes DW, Biji HA, Jansen J, Tytgat GN: Treatment of Crohn's disease with antitumor necrosis factor chimeric monoclonal antibody (CA2). Gastroenterology 109:129–135, 1995

    Google Scholar 

  118. Strober W, Ehrhardt RO. Cronic Intestinal inflammation: An unexpected outcome of cytokine or T cell receptor mutant mice. Cell 75:203–205, 1993

    Google Scholar 

  119. Takahashi I, Kiyono H, Hamada S: CD4+ T-cell population mediates development of inflammatory bowel disease in T-cell receptor alpha chain-deficient mice. Gastroenterology 112:1876–1886, 1997

    Google Scholar 

  120. Neurath MF, Pettersson S, Meyer zum Buschenfelde K-H, Strober W. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kB abrogates established experimental colitis in mice. Nature Med 2:998–1003, 1996

    Google Scholar 

  121. Neurath M, Fuss I, Pasparakis M, Alexopoulos L, Haralambous S, Meyer zum Buschenfeld K-H, Strober W, Kollias G: Predominant pathogenic role of tumor necrosis factor alpha in experimental colitis in mice. Eur J Immunol 27:27–34, 1997

    Google Scholar 

  122. Sartor BD, Roth HC, Sellon RK: Microbial factors in chronic intestinal inflammation. Curr Opin Gastroenterol 12:327–333, 1996

    Google Scholar 

  123. Meyer AL, Benson JM, Gienapp IE, Cox KI, Whitacre CC: Suppression of murine chronic relapsing experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein. J Immunol 157:4230–4238, 1996

    Google Scholar 

  124. Brod S, Al-Sabbagh R, Hafler D, Weiner H: Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Supression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig. Ann Neurol 29:615–622, 1991

    Google Scholar 

  125. Zhang ZJA, Davidson L, Eisenbarth G, Weiner HL: Suppression of diabetes in NOD mice by oral administration of porcine insulin. Proc Natl Acad Sci USA 88:10252–10256, 1991

    Google Scholar 

  126. Tian J, Atkinson MA, Clare-Salzler M, Forsthuber T, Lehmann PV, Kaufman DL: Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J Exp Med 183:1561–1567, 1996

    Google Scholar 

  127. Thompson HSG Staines NA: Gastric administration of type II collagen delays the onset and severity of collagen-induced arthritis in rats. Clin Exp Immunol 64:581–586, 1986

    Google Scholar 

  128. Peterson KE, Braley-Mullen H: Suppression of murine experimental autoimmune thyroiditis by oral administration of porcine thyroglobulin. Cell Immunol 166:123–130, 1995

    Google Scholar 

  129. Sayegh MH, Zhang ZJA, Hancock WW, Kwok CA, Carpenter CB, Weiner HL: Down-regulation of the immune response to histocompatibility antigen and prevention of sensitization by skin allografts by orally administered autoantigen. Transplantation 53:163–166, 1992

    Google Scholar 

  130. Wang ZY, Huang, J, Olsson T, He B, Link H: B cell responses to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis. J Neurol Sci 128:167–174, 1995

    Google Scholar 

  131. Husby S, Mestecky J, Moldoveanu Z, Holland S, Elson CO: Oral tolerance in humans. T cell but not B cell tolerance after antigen feeding. J Immunol 152:4663–4670, 1994

    Google Scholar 

  132. Weiner HL: Trearment of autoimmune diseases by oral tolerance to autoantigens. Autoimmunity 15(Suppl):6–7, 1993

    Google Scholar 

  133. Sieper J, Kary S, Sörensen H, Alten R, Eggens U, Hüge W, Hiepe F, Kühne A, Listing J, Ulbrich N, Braun J, Zink A, Mitchison NA: Oral type II collagen treatment in early rheumatoid arthritis. Arthr Rheum 39:41–51, 1996

    Google Scholar 

  134. Nussenblatt R, Whitcup S, de Smet M, Caspi R, Kozhich A, Weiner H, Vistica B, Gery I: Intraocular inflammatory disease (uveitis) and the use of oral tolerance: A status report. Ann NY Acad Sci 778:325–327, 1996

    Google Scholar 

  135. Nussenblatt RB, Gery I, Weiner HL, Ferris FL, Shiloach J, Remaley N, Perry C, Caspi RR, Hafler DA, Foster CS, Whitcup SM. Treatment of uveitis by oral administration of retinal antigens: Results of a phase I/II randomized masked trial. Am J Ophthalmol 123:583–592, 1997

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Strober, W., Kelsall, B. & Marth, T. Oral Tolerance. J Clin Immunol 18, 1–30 (1998). https://doi.org/10.1023/A:1023222003039

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1023222003039

Navigation